pulmonary drug delivery

Tyvaso DPI: Drug-device characteristics and patient clinical considerations

McEvoy C, Argula R, Sahay S, Shapiro S, Eagan C, Hickey AJ, Smutney C, Dillon C, Winkler T, Davis B, Broderick M, Burger C. Tyvaso[...]

By sjmartinez • November 16, 2023

Pulmonary Delivery of Specialized Pro-Resolving Mediators-Based Nanotherapeutics Attenuates Pulmonary Fibrosis in Preclinical Animal Models

Li J, Xiao Y, Zhang Y, Li S, Zhao M, Xia T, Meng H. Pulmonary Delivery of Specialized Pro-Resolving Mediators-Based Nanotherapeutics Attenuates Pulmonary Fibrosis in[...]

By sjmartinez • August 4, 2023